| Shalabh Gupta, M.D. | Chief Executive Officer | FY2025 | |
| Pramod Gupta, Ph.D. | Executive VP Pharmaceutical and Business Operations | FY2025 | |
| Doug Jermasek | Executive VP, Corporate Strategy | FY2025 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.